| Jiang, Erlie |
TQ05105-III-01, NCT06682169: Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease |
|
|
| Recruiting | 3 | 182 | RoW | Rovadicitinib, Imatinib, Methotrexate, Mycophenolate mofetil, Rituximab | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Graft-versus-host Disease | 10/29 | 12/30 | | |
| Recruiting | 2/3 | 142 | RoW | avatrombopag, Doptelet, Placebo | Peking University People's Hospital, Xiangya Hospital of Central South University, Sichuan Provincial People's Hospital, First Affiliated Hospital of Harbin Medical University, The First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital of Xinjiang Medical University, Shanxi Bethune Hospital, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Tang-Du Hospital, The First Affiliated Hospital of Nanchang University | Thrombocytopenia, Stem Cell Transplant Complications | 10/24 | 10/25 | | |
ABSK021-201, NCT06186804: A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD) |
|
|
| Enrolling by invitation | 2 | 64 | RoW | ABSK021 | Abbisko Therapeutics Co, Ltd | cGvHD | 10/26 | 12/26 | | |
NCT06608342: Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia |
|
|
| Recruiting | 2 | 20 | RoW | Autologous hematopoietic stem cell transplantation combined with CD19-CART | Institute of Hematology & Blood Diseases Hospital, China, Juventas Cell Therapy Ltd. | Acute Lymphoblastic Leukemia ALL | 05/26 | 05/28 | | |
NCT06427330: Phase II Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia |
|
|
| Recruiting | 2 | 21 | RoW | Inotuzumab ozogamicin | Institute of Hematology & Blood Diseases Hospital, China | Acute Lymphoid Leukemia | 06/25 | 06/26 | | |
NCT06608732: Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission. |
|
|
| Recruiting | 2 | 20 | RoW | Inaticabtagene autoleucel | Institute of Hematology & Blood Diseases Hospital, China, Juventas Cell Therapy Ltd. | B-cell Acute Lymphoblastic Leukemia | 07/28 | 07/28 | | |
NCT05823675: Safety and Clinical Activity of Itolizumab in aGVHD |
|
|
| Recruiting | 1 | 44 | RoW | Itolizumab, T1h, Methylprednisolone, Methylprednisolone Sodium Succinate | Biotech Pharmaceutical Co., Ltd. | Acute Graft Versus Host Disease | 10/24 | 02/25 | | |
NCT05335226: Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia |
|
|
| Recruiting | N/A | 116 | RoW | Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation, haploidentical hematopoietic stem cell transplantation | Institute of Hematology & Blood Diseases Hospital | Acute Leukemia | 11/23 | 03/24 | | |
NCT06490549: An Epidemiological Study to Investigate the Characteristics of RSV Infection in Adult Hematopoietic Cell Transplant Recipients or Hematological Malignancies Patients in Tianjin HI (Hematology Institute) |
|
|
| Recruiting | N/A | 500 | RoW | RSV infection observation cohort | Institute of Hematology & Blood Diseases Hospital, China | RSV Infection | 06/25 | 06/25 | | |
NCT05531266: Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease |
|
|
| Recruiting | N/A | 182 | RoW | hUC-MSCs, glucocorticoids | Institute of Hematology & Blood Diseases Hospital | aGVHD | 03/24 | 03/25 | | |
NCT05727917: Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation |
|
|
| Recruiting | N/A | 78 | RoW | Hetrombopag, placebo | Institute of Hematology & Blood Diseases Hospital | Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation | 05/24 | 10/24 | | |
NCT06102694: Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy |
|
|
| Recruiting | N/A | 300 | RoW | | Institute of Hematology & Blood Diseases Hospital, China | Thrombotic Microangiopathies, Hematopoietic Stem Cell Transplantation | 01/25 | 12/25 | | |
NCT04725942: Posaconazole for Pulmonary Fungal Infection Prophylaxis in Hematopoietic Stem Cell Transplantation Patients |
|
|
| Not yet recruiting | N/A | 360 | RoW | Oral Posaconazole tablets | Institute of Hematology & Blood Diseases Hospital, Shanxi Bethune Hospital, The Second Hospital of Hebei Medical University, Tianjin Medical University Cancer Institute and Hospital | Pulmonary Fungal Infection | 04/23 | 04/23 | | |
| Wang, Yajie |
TQ05105-III-01, NCT06682169: Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease |
|
|
| Recruiting | 3 | 182 | RoW | Rovadicitinib, Imatinib, Methotrexate, Mycophenolate mofetil, Rituximab | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Graft-versus-host Disease | 10/29 | 12/30 | | |
NCT05741099: Application and Research of Mesenchymal Stem Cells in Alleviating Severe Development of COVID-19 Infection |
|
|
| Recruiting | 1/2 | 20 | RoW | Umbilical cord mesenchymal stem cells implantation, Comparator | Hebei Medical University | COVID-19 | 01/24 | 01/25 | | |
NCT06421831: Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients |
|
|
| Recruiting | 1/2 | 21 | RoW | GC101 | GeneCradle Inc | Spinal Muscular Atrophy Type 3 | 12/26 | 12/28 | | |
| Liu, Yanbin |
NCT06198764: A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection |
|
|
| Recruiting | 3 | 80 | RoW | Colistimethate sodium for injection, Meropenem for Injection, Coly Mycin M Injectable Product | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Mental Health Issue | 03/26 | 03/26 | | |
